Get started
Author

Heena R. Bhojwani

Observed names: H Bhojwani, Heena Bhojwani
ORCID: 0000-0003-2589-6336
Observed ORCID: 0000-0003-2589-6336
OpenAlex ID: A5084873059
Pharmacophore and Docking Guided Virtual Screening Study for Discovery of Type I Inhibitors of VEGFR-2 Kinase
2017 · Heena R. Bhojwani, Urmila J. Joshi · Current Computer - Aided Drug Design · 22
Evaluation of Benzamide-Chalcone Derivatives as EGFR/CDK2 Inhibitor: Synthesis, In-Vitro Inhibition, and Molecular Modeling Studies
2021 · Akshada Joshi, Heena Bhojwani, et al. · Anti-Cancer Agents in Medicinal Chemistry · 12
Synthesis and biological evaluation of benzamide‐chalcone hybrids as potential c‐Met kinase and COX‐2 inhibitors
2023 · Heena Bhojwani, Khushboo Begwani, et al. · Archiv der Pharmazie · 7
Strategies to select the best pharmacophore model: a case study in pyrazoloquinazoline class of PLK-1 inhibitors
2017 · Akshada J. Joshi, Heena R. Bhojwani, et al. · Medicinal Chemistry Research · 6
Design, synthesis, and biological evaluation of 2, 4-dichlorophenoxyacetamide chalcone hybrids as potential c-Met kinase inhibitors
2022 · Heena Bhojwani, Sanskruti Patil, et al. · Medicinal Chemistry Research · 5
Cinnamamide-chalcone derivatives as CDK2 inhibitors: synthesis, pharmacological evaluation, and molecular modelling study
2022 · Akshada J. Joshi, Heena R. Bhojwani, et al. · Journal of the Iranian Chemical Society · 5
PDF
Homology Modelling, Docking-based Virtual Screening, ADME Properties, and Molecular Dynamics Simulation for Identification of Probable Type II Inhibitors of AXL Kinase
2021 · Heena R. Bhojwani, Urmila J. Joshi · Letters in Drug Design & Discovery · 4
Assessing cilnidipine and its combination usage in Indian settings: a knowledge, attitude, and practice survey
2024 · Mukesh Shete, Ashish Saxena, et al. · International Journal of Advances in Medicine · 3
PDF
Selection of Best Crystal Structure for Initiating Docking-based Virtual Screening Studies of Cdk2 Inhibitors: a Cross-docking and Dud Set Validation Approach
2019 · A. Joshi, H Bhojwani, et al. · INDIAN DRUGS · 3
Optimizing the Diagnosis and Management of Nocturnal Hypertension: An Expert Consensus from India
2025 · H N Mishra, Sadanand Shetty, et al. · Journal of the Association of Physicians of India · 2
Management of Hypertension and Associated Comorbidities: An Expert Consensus Statement from India
2025 · HN Mishra, Sadanand Shetty, et al. · Journal of the Association of Physicians of India · 1
Integrative computational approaches in pharmaceuticals: Driving innovation in discovery and delivery
2025 · Heena R. Bhojwani, Nikhil P. Rajnani, et al. · Advances in pharmacology · 1
Integrated pharmacophore‐based screening and docking strategy for identifying type II inhibitors of VEGFR‐2 kinase
2024 · Sanskruti Patil, Heena Bhojwani, et al. · Next research. · 1
Role of vildagliptin and its combination in type 2 diabetes mellitus management: a knowledge, attitude, and practice survey among Indian healthcare professionals
2024 · Pramila Kalra, Mala Dharmalingam, et al. · International Journal of Research in Medical Sciences
PDF
Improving cardiovascular outcomes in type 2 diabetes mellitus: Role of dapagliflozin and metformin
2024 · Dr. Subhash Sonawala, Dr. Anuradha Kapoor, et al. · International Journal of Cardiology Research
PDF
Works count: 15
Citation count: 72
H-index: 5
I10-index: 2
Year
Topic
Type